Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Abroad (travel likely)Recruiting

Conditions

Breast Neoplasms · Carcinoma, Ductal, Breast · Receptors, Estrogen (for ER-positive Requirement)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • University of Alabama at Birmingham, Birmingham, Alabama, United States

    Contact: Principal Investigator (Nusrat Jahan, MD)
  • Mayo Clinic Arizona, Phoenix, Arizona, United States

    Contact: Principal Investigator (Shakeela Bahadur, MD)
  • Honor Health Research Institute, Scottsdale, Arizona, United States

    Contact: Study coordinator (Nathan Solod)
    Contact: Principal Investigator (Abhimanyu Ghose, MD)
    Contact: Principal Investigator (Wishwdeep Dhillon, MD)
  • University of Arizona Cancer Center, Tucson, Arizona, United States

    Contact: Principal Investigator (Sima Ehsani, MD)
  • Adventist Health/AIS Cancer Center, Bakersfield, California, United States

    Contact: Principal Investigator (Madiha Naseem, MD)
  • Marin Cancer Care, Greenbrae, California, United States

    Contact: Principal Investigator (Cyrus Mazidi, MD)
  • Loma Linda University, Loma Linda, California, United States

    Contact: Principal Investigator (Gayathri Nagaraj, MD)
  • UCLA David Geffen School of Medicine, Santa Monica, California, United States

    Contact: Principal Investigator (Marla Lipsyc-Sharf, MD)
  • Stockton Hematology Oncology Medical Group, Stockton, California, United States

    Contact: Study coordinator (Lenzi Cook) · lcook@shomg.net
    Contact: Principal Investigator (Ajithkumar Puthillath, MD)
  • Kaiser Permanente NorCal, Vallejo, California, United States

    Contact: Principal Investigator (Jennifer Suga, MD)
  • Hartford Healthcare Institute, Hartford, Connecticut, United States

    Contact: Principal Investigator (Richard Zelkowitz, MD)
  • Yale Cancer Center, New Haven, Connecticut, United States

    Contact: Principal Investigator (Lajos Pusztai, MD)
  • Baptist MD Anderson, Jacksonville, Florida, United States

    Contact: Study coordinator (Vanessa Tolsa)
    Contact: Principal Investigator (Dayra Avila-Lima, MD)
  • Mayo Clinic Florida, Jacksonville, Florida, United States

    Contact: Principal Investigator (Pooja Advani, MD)
  • Jupiter Medical Cancer, Jupiter, Florida, United States

    Contact: Principal Investigator (Danielle Krol, MD)
  • Miami Cancer Institute, Miami, Florida, United States

    Contact: Principal Investigator (Reshma Mahtani, DO)
  • Ocala Oncology, Ocala, Florida, United States

    Contact: Principal Investigator (Rama Balaraman, MD)
  • Northwestern University, Chicago, Illinois, United States

    Contact: Study coordinator (Nicole Grzywacz)
    Contact: Principal Investigator (William Gradishar, MD)
  • Northwest Cancer Center, Dyer, Indiana, United States

    Contact: Study coordinator (Mariela Abad) · Mariela.Abad@usoncology.com
    Contact: Principal Investigator (Shruti Singh, MD)
  • New England Cancer Specialists, Westbrook, Maine, United States

    Contact: Principal Investigator (Chiara Battelli, MD)
  • Karmanos Cancer Center - Wayne State University, Detroit, Michigan, United States

    Contact: Study coordinator (Allison Wolgast)
    Contact: Principal Investigator (Jailan Elayoubi)
  • Cancer & Hematology Centers, Grand Rapids, Michigan, United States

    Contact: Study coordinator (Jared Hogeterp)
    Contact: Principal Investigator (Haritha Reddy)
  • Munson Medical Center Cowell Family Cancer Center, Traverse City, Michigan, United States

    Contact: Principal Investigator (Yelena Kier, DO)
  • Mayo Clinic, Rochester, Minnesota, United States

    Contact: Principal Investigator (Karthik Giridhar, MD)
  • Mercy Health - Sindelar Cancer Center, St Louis, Missouri, United States

    Contact: Principal Investigator (Yifan Tu, MD)
  • Mercy Health - Pratt Cancer Center, St Louis, Missouri, United States

    Contact: Principal Investigator (Bethany Sleckman, MD)
  • Cooper Health, Camden, New Jersey, United States

    Contact: Principal Investigator (Kamel Abou-Hussein, MD)
  • Rutgers, New Brunswick, New Jersey, United States

    Contact: Study coordinator (Stephanie Farias)
    Contact: Principal Investigator (Mridula George, MD)
  • New York Cancer and Blood Specialists, Babylon, New York, United States

    Contact: Study coordinator (Ivanna Novoa)
    Contact: Principal Investigator (Richard Zuniga)
  • Atrium Levine Cancer Institute, Charlotte, North Carolina, United States

    Contact: Principal Investigator (Arielle Heeke, MD)
  • Allegheny (AHN), Pittsburgh, Pennsylvania, United States

    Contact: Principal Investigator (Joseph Liput, MD)
  • Sanford Health, Sioux Falls, South Dakota, United States

    Contact: Principal Investigator (Allison Watson, MD)
  • West Cancer Center, Germantown, Tennessee, United States

    Contact: Study coordinator (Karen Axley)
    Contact: Principal Investigator (Gary Tian, MD)
  • Vanderbilt, Nashville, Tennessee, United States

    Contact: Principal Investigator (Brent Rexer, MD)
  • Houston Methodist Hospital, Houston, Texas, United States

    Contact: Principal Investigator (Akshjot Puri, MD)
  • Northwest Medical Specialties, PLLC, Puyallup, Washington, United States

    Contact: Principal Investigator (Sibel Blau, MD)
  • Fred Hutch Cancer Center, Seattle, Washington, United States

    Contact: Principal Investigator (Lynn Symonds, MD)
  • MultiCare Cancer Institute, Tacoma, Washington, United States

    Contact: Principal Investigator (Blair Irwin, MD)
  • West Virginia University, Morgantown, West Virginia, United States

    Contact: Principal Investigator (Bei Jiang, MD)
Study leads
  • Angel Rodriguez, MD

    Study Director

    Natera, Inc.